From Neural Sensing to Stimulation: An Interdisciplinary Roadmap for Neurotechnology

Neurotechnologies are transforming how we measure, interpret, and modulate brain-body interactions, integrating real-time sensing, computation, and stimulation to enable precise physiological control. They hold transformative potential across clinical and non-clinical domains, from treating disorders to enhancing cognition and performance. Realizing this potential requires navigating complex, interdisciplinary challenges spanning neuroscience, materials science, device engineering, signal processing, computational modelling, and regulatory and ethical frameworks. This Perspective presents a strategic roadmap for neurotechnology development, created by early-career researchers, highlighting their role at the intersection of disciplines and their capacity to bridge traditional silos. We identify five cross-cutting trade-offs that constrain progress across functionality, scalability, adaptability, and translatability, and illustrate how technical domains influence their resolution. Rather than a domain-specific review, we focus on shared challenges and strategic opportunities that transcend disciplines. We propose a unified framework for collaborative innovation and education, highlight ethical and regulatory priorities, and outline a timeline for overcoming key bottlenecks. By aligning technical development with translational and societal needs, this roadmap aims to accelerate equitable, effective, and future-ready adaptive neurotechnologies, guiding coordinated efforts across the global research and innovation community.

💡 Research Summary

The paper “From Neural Sensing to Stimulation: An Interdisciplinary Roadmap for Neurotechnology” presents a forward‑looking strategic plan that unites sensing, computation, and actuation into closed‑loop neuro‑devices capable of precise physiological control. Rather than a conventional review of individual technologies, the authors—early‑career researchers (ECRs) themselves—focus on the systemic trade‑offs that shape progress across four dimensions: functionality, scalability, adaptability, and translatability. They identify five cross‑cutting dilemmas: (1) signal fidelity versus device miniaturization, (2) universal platforms versus patient‑specific customization, (3) real‑time high‑performance decoding versus low‑power operation, (4) biocompatibility versus long‑term durability, and (5) rapid innovation versus ethical‑regulatory transparency. For each dilemma, the paper maps the relevant technical domains—materials science, micro‑fabrication, electronics, embedded AI, and clinical validation—and proposes concrete mitigation pathways.

Materials strategies such as modular micro‑fabrication, graphene‑based electrodes, and bio‑inspired self‑assembly aim to deliver high‑resolution sensing while preserving tissue health. In electronics, ultra‑low‑power ASICs that emulate spiking neural networks are paired with energy‑harvesting schemes to sustain continuous operation. Computationally, federated learning and on‑device inference protect patient privacy and satisfy emerging data‑governance regulations. Clinically, digital‑twin simulations enable pre‑clinical optimization of stimulation parameters, and standardized data layers facilitate multi‑site trials and regulatory submissions.

A central thesis is that ECRs, positioned at the intersection of multiple disciplines, can act as “bridges” that dissolve traditional silos. The authors advocate for interdisciplinary curricula, open‑source hardware/software ecosystems, and global collaboration platforms (e.g., NeuroTechX, IEEE Brain Initiative) to accelerate skill acquisition and knowledge exchange. Ethical considerations receive equal weight: transparent data governance, pre‑emptive risk assessment frameworks, and inclusive stakeholder engagement are embedded in the roadmap.

The timeline is divided into three phases. In the first 1–3 years, the focus is on establishing standards, building prototype testbeds, and conducting pilot human studies. Years 4–6 target large‑scale clinical pilots, manufacturing scale‑up, and the refinement of regulatory pathways. The final 7–10 year horizon envisions fully certified, market‑ready neuro‑technologies that are affordable, equitable, and integrated into diverse applications ranging from therapeutic neuromodulation to cognitive enhancement and brain‑machine interfacing.

By aligning technical development with societal needs, the roadmap seeks to accelerate the transition from laboratory breakthroughs to safe, effective, and globally accessible neurotechnologies. It underscores that progress will be most rapid when engineering excellence, rigorous science, and responsible governance proceed in lockstep, guided by a new generation of interdisciplinary innovators.